Main article: Human heart
Shunting
Bypass - creating an additional path to bypass the affected area of any vessel using a cavity plastic modeling operation. In simple words - creating a workaround for the flow of blood.
The operation is performed under general anesthesia. In general, a section of the subcutaneous vein of the thigh is chosen as the material for the shunt, since it has a sufficiently large diameter in the section, and the removal of its section almost does not affect the blood flow of the limb.
For 2019, coronary bypass surgery, as the "gold standard," is the most effective method of restoring blood flow in the coronary arteries of the heart.
Heart transplantation
2022: For the first time in Russia, a successful transplantation of the artificial left ventricle of the heart was carried out
For the first time in Russia, a successful transplantation of the artificial left ventricle of the heart was carried out. Such an operation was carried out by military cardiac surgeons from the A. A. Vishnevsky Central Military Clinical Hospital, the Ministry of Defense of the Russian Federation reported on September 22, 2022.
 | The first transplant of the "mechanical heart" - the artificial left ventricle - was performed by military cardiac surgeons in chronic heart failure in a patient with dilated cardiomyopathy, the agency said in a statement quoted by TASS. |  |
The transplant took place in a unique hybrid complex of a cardiac surgery center led by Doctor of Medical Sciences, Professor Alexander Lishchuk. It is noted that the Vishnevsky Military Hospital has created the only single operating complex in Russia with a resuscitation chamber, a blood harvesting station, a defibrillation system, breathing apparatus, the ability to make express histology and many other functions.
With its help, it was possible to transform the unified workspace of specialists in diagnostic procedures and cardiac surgery teams. Together with a team of cardiac surgeons, anesthesiologists, transfusiologists and engineers worked in the operating room to provide functional configuration of the system.
| | With this device, we unload the stretched left ventricle overloaded with volume, reduce the tension of its walls. Thus, we give him the opportunity to further restore his power of contraction and the function of the heart as a whole. With this course, it is possible to provide long-term mechanical support of the left ventricle with contraindications to further heart transplantation, - explained Alexander Lishchuk. | |
The operating complex allows you to simultaneously work with several areas of the human body and save time in helping a patient who has received multiple injuries, injuries, has a number of serious, serious diseases.[1]
2024
Robot surgeon introduced to replace heart valves
On December 11, 2024, Capstan Medical announced the development of a robotic system to replace heart valves. The complex allows carrying out minimally invasive procedures. Read more here.
A robot surgeon for heart operations has been commissioned. He treats arrhythmia
On November 6, 2024, Stereotaxis announced the start of operation of its Genesis robotic magnetic navigation (RMN) platform. It began to be used by doctors at the University of Kansas Health System in the treatment of arrhythmia. Read more here.
Russia has developed a technology for preserving the life of a donor heart for 10 hours. Artificial lungs are used for this
In October 2024, Russian scientists talked about the creation of an innovative technology that allows, according to them, to maintain the viability of a donor heart outside the body for up to 10 hours. A key feature of the method is the use of artificial lungs, which significantly increases the transport time of the organ for transplantation. Read more here.
Russian surgeons conducted the world's first operation to introduce heart rhythm driver cells
At the end of September 2024, the first operation in the world to implant artificially grown rhythm driver cells in the heart of an animal was carried out at the Academician Meshalkin National Medical Research Center (NMIC) in Novosibirsk. This unique achievement opens up new perspectives in the treatment of arrhythmia without the need to install electrocardiostimulants. Read more here.
An innovative device to eliminate blockage of the pulmonary arteries has come out. Transactions are already in progress
At the end of September 2024, AngioDynamics announced the start of a clinical study of the AlphaVac F18 system for the treatment of pulmonary embolism (PE). The AlphaVac F18 system is a mechanical aspiration device for emergency care that allows non-surgical removal of thrombotic clots from the pulmonary arteries. The device is equipped with an ergonomic handle, 18F cannula with an angle of 85 degrees, an obturator and an assembly of a waste bag. Read more here.
Perm doctors for the first time in the world performed surgery on the aorta with a working heart
In August 2024, it became known that the doctors of the Federal Center for Cardiovascular Surgery (FCSSH) named after S. G. Sukhanov in Perm for the first time in the world successfully performed an operation on the aorta with a working heart. Read more here
For the first time in Russia, a robotic operation for prosthetics of the abdominal aorta was carried out
In Moscow, at the end of June 2024, for the first time in Russia, a robotic operation for prosthetics of the abdominal aorta was successfully carried out. This unique surgical intervention was performed by specialists from the Clinic for Cardiovascular Surgery of the Sechenov University using the da Vinci robotic system. Read more here
Russian heart surgeons were the first in the world to successfully implant a vascular prosthesis with petals of aortic root sinuses
Russian heart surgeons from Sechenov University were the first in the world to successfully implant a vascular prosthesis with root sinus petals. aortas The press service of the university told about this on April 16, 2024. More. here
2023
Intracardiac pressure control device without chest piercing is presented
On November 8, 2023, Swedish startup Acorai introduced non-invasive pressure measurement technology in the heart chambers. A sensory system called Save is designed to simplify and make more effective the treatment of heart failure. Read more here.
Robotic surgeons in Russia began to conduct open heart operations
Robotic surgeons in Russia began to conduct open heart operations. This was announced at the end of October 2023 at the V.A. Almazov National Medical Research Center. Read more here.
The world's first artificial heart valve has been released to treat the most popular heart disease
On October 19, 2023, Edwards Lifesciences announced the release of a system called Evoque to replace the tricuspid valve. The product is intended for the treatment of tricuspid regurgitation - one of the most common heart defects. Read more here.
For the first time in Russia, a pericardial prosthesis was created and used during heart surgery
For the first time in Russia, a prosthesis from pericardial tissues was created and used during heart surgery. This achievement was reported in September 2023 at the E. N. Meshalkin National Medical Research Center (NMIC).
For the first time in Russian practice, cardiac surgeons of the center designed a tubular prosthesis from the patient's own peri-cardiac tissues. A rare cardiovascular pathology was found in the patient. It consisted in the fact that not all pulmonary veins are associated with the heart, so part of the blood is discharged without entering the left atrium.
The arrangement of veins and vessels is similar to a curved saber because of this, a similar kind of heart defect is called "Turkish saber" syndrome. An insufficient amount of blood enters the heart, and one lung is smaller in size and because of this, the body has increased the network of vessels for feeding the lung.
It was necessary to build up the vessel, and the team made a non-standard decision - to use the tissues of the patient himself. The pericardium ("heart bag") of the patient was taken and a prosthetic vessel of a predetermined diameter was formed from it so that the inner lumen in the filled state was 15 mm.
| | We did not want to sew a conventional synthetic prosthetic vessel, as this dramatically increases the risk of thrombosis. Biological tissues are preferable, after all, the patient is a teenager, a young organism, - explains the cardiovascular surgeon of the Department of Congenital Heart Defects of the National Medical Research Center named after Meshalkina Timur Khapaev. | |
The entire operation, together with the manufacture of the prosthesis, took 2.5 hours and passed without complications. After 6 months, the control study confirmed the good work of the vessel formed by the surgeons: the outflow of blood from the right lung does not meet any obstacles on the way, there are no thromboses, the pressure in the pulmonary system decreased by 1.5 times. The teenager returned to his studies.[2]
Boston Scientific releases heart implant that prevents strokes
On September 6, 2023, Boston Scientific announced the Watchman FLX Pro heart implant, the use of which helps prevent stroke. Read more here.
A device has been released to remove blood clots from the right heart without surgery
On August 15, 2023, AngioDynamics announced the AngioVac system, designed to nonsurgically remove blood clots from the right heart. Read more here.
After a heart valve prosthetics operation, the first woman in Russia was able to give birth to a child
On July 31, 2023, it became known about the first case in Russia when, after an operation to prostrate a heart valve, a woman was able to give birth to a child. This was told in the Ministry of Health of the Russian Federation. Read more here.
Cardiac surgeons in Russia have learned to maintain a donor heart 1.5 times longer than usual
Cardiac surgeons from the E. N. Meshalkin National Medical Research Center in Novosibirsk were able to extend the life of the donor heart from four to six hours. This became known in June 2023. Read more here.
In Novosibirsk, created a seamless hybrid prosthesis for dissection of the thoracic aorta
In June 2023, the E. N. Meshalkin National Medical Research Center (NMIC) in Novosibirsk announced the creation of a hybrid prosthesis with a seamless joint for rapid implantation in thoracic aortic dissection, a disease with high mortality that requires emergency intervention. Read more here.
In Russia, created the world's first aortic prosthesis with a biodegradable framework
In June 2023, it became known about the creation of a new model of a prosthesis for patients with aortic dissection at the ACOD B.V. Petrovsky. The upgraded design will save patients from possible negative consequences of surgery. Read more here.
In Russia, created a prosthesis for the correction of heart disease in newborns
At the National Medical Research Center of Cardiovascular Surgery named after A.N. Bakuleva, the Ministry of Health of Russia has developed and patented a new method of surgical treatment of congenital heart disease, in which the patient's own tissues are used. The press service of the center announced this on January 23, 2023. Read more here.
Implantation of the first Russian stent-graft
Krasnoyarsk surgeons of the Federal Center for Cardiovascular Surgery successfully implanted the first Russian multi-wound stent-graft in a patient with dissection of the thoracic and abdominal aorta. The press service of the Ministry of Health of the Russian Federation announced this on January 18, 2023. Read more here.
2022
For the first time in Russia, a child was installed a heart valve from donor tissues
In November 2022, in the center of congenital heart defects and pediatric cardiorematology of the Samara Regional Clinical Cardiological Dispensary named after V.P. Polyakov, for the first time in Russia, a unique operation was performed - a homograph valve was installed. This is an implantable prosthesis consisting of specially treated donor tissues of the patient.
The patient was an 8-year-old boy who had an atrial ventricular septal defect at birth. When he turned six months old, the doctors installed an artificial valve on his heart, and when the child grew up, the valve had to be changed. After such an operation, patients need to constantly take blood-thinning drugs, and the child has to live with certain restrictions. Therefore, Samara children's cardiac surgeons decided to install a valve from donor tissues to the boy - a homograph.
| | This is the latest development of scientists from St. Petersburg. The new valve will allow him to lead a normal lifestyle, without additional drugs. We are satisfied with the result, immediately on the operating table we made a control EGC through the esophagus and assessed the work done. I hope our new experience will give an impetus to the replication of such an operation with this pathology, - explained the head. Department of Cardiac Surgery and Cardiorematology, SOKKD named after V.P. Polyakova Sergei Shorokhov. | |
The operation, carried out by Samara cardiac surgeons, was technically complex and lasted about 4 hours. Now the child can live a full life and engage in physical education and sports. The operation was carried out free of charge as part of a high-tech medical care program, according to the information policy department of the Samara region.
| | Now the son can play sports, physical activity. I am very grateful to the doctors. The most important thing is to believe in your child, and believe the doctors who will do everything so that everything is fine with the child, - said the boy's mother Angelina.[3] | |
World's first partial heart transplant performed
In early September 2022, a team of specialists from the Duke Health Clinic performed the world's first partial heart transplant, in which living arteries and valves from a fresh donor heart were connected to the patient's existing heart.
The goal of the surgery was to allow the valves to grow with the pediatric patient over time, increasing life expectancy. The team believes a similar approach could be used to install new donor heart valves to countless other children with heart defects.
The operation was performed on newborn Owen Monroe, weighing 2.26 kg. His family hails from North Carolina State, but he was born in Duke after his parents learned he had a condition called congenital heart disease, in which his two main heart arteries were fused together. Worse, his one vessel was fitted with a leaky valve, making it unlikely that Owen could survive the wait for a full heart transplant.
Usually, children in situations like Owen's have two preserved cadaveric arteries transplanted with valves. But the implanted tissue used in this procedure does not grow with the child's own heart because it is not alive. Pediatric patients require several follow-up open-heart surgeries to replace the valves with larger ones, significantly reducing their lifespan.
In a partial heart transplant, Joseph Turek, MD, PhD, and a team from Duke Health Clinic, including pediatric cardiac surgeon Nicholas Andersen, MD, and a large team of anesthesiologists, nurses, technicians and support staff, used live tissue and valves. The tissue was obtained from a donor heart that had strong valves but could not be used for a complete transplant due to the muscle condition. The team's efforts to implant valves that can grow with the patient have been successful. After the surgery, performed on 22 April 2022, Owen is showing significant growth and improvement and his prognosis remains favourable.
Experts at Duke Health Clinic hope a similar approach could be used to treat common cases of valve replacement in children by performing a one-time operation to implant fresh donor tissue that can grow with the child.[4]
Unique Mitral Heart Valve Treatment Device Entered the Market
On August 22, 2022, Pi-Cardia introduced a unique device for the treatment of mitral heart valveShortCut mitral. It is used to separate the flaps before transcatheter valve treatment in patients at risk of coronary obstruction, after replacement of the aortic valve or obstruction of the left ventricular otic tract. Read more here.
Roszdravnadzor registered the first domestic aortic valve prosthesis delivery system
At the end of March 2022, Roszdravnadzor registered the first domestic delivery system for an aortic valve prosthesis. This product was developed by NPP "MedInzh." Read more here.
Death after gene-modified heart transplant
In March 2022, the first patient with a transplanted genetically modified pig heart died at the University of Maryland Medical Center. The initial transplant operation was carried out in early 2022. Read more here.
Removing a shard near the heart
Seriously wounded during a special operation of Russia in Ukraine, with a fragment at the heart, from Donbass was taken by ambulance to Moscow. A unique operation to extract the fragment, which was literally next to the heart, was carried out by Alexander Lishchuk - Doctor of Medical Sciences, Professor, Head of the Cardiac Surgery Center of the Ministry of Defense of the Russian Federation.
In Russia, created software to work out heart transplants
In March 2022, the St. Petersburg State Electrotechnical University "LETI" named after V.I. Lenin announced the development of software designed to work out heart transplants. The solution was created on the Matlab platform. Read more here.
Genetically modified pig heart successfully transplanted into humans for the first time
In January 2022, a genetically modified pig heart was successfully transplanted into humans for the first time. The operation was carried out by doctors at the University of Maryland, the patient was 57-year-old David Bennett, who suffered from terminal terminal heart disease. Read more here.
2021
Britain has developed a technique for heart transplantation with blood group incompatibility
On October 22, 2021, it became known that Britain the was developed. procedure for heart transplantation with blood group incompatibility
As reported, twice as many children will get a chance for a heart transplant thanks to a technique developed by specialists from the Great Ormond Street Clinic (GOSH) and the Institute of Cardiovascular Research at University College London (UCL ICS) with financial support from the British Heart Foundation (BHF). The protocol is already being applied at the Great Ormond Street Clinic. Read more here.
Russia carried out the world's first operation on the aortic valve of the heart without a chest incision
Cardiac surgeons Meshalkin National Medical Research Center Novosibirsk in performed the world's first valve operation aortas hearts without a chest incision. This was reported in the clinic in September 2021.
Successful surgical treatment was performed on a 36-year-old patient with heart aortic valve disease and aneurysmally dilated aorta. The patient has not a three-, but a bicuspid valve of the heart. He began to let in blood, the condition worsened, so the doctors decided to operate. The patient's aorta was positioned to extend beyond the edge of the sternum.
| | This is always a clue to the surgeon that miniinvasive access can be made on the right side. It seems to everyone how so? The heart ─ on the left, and access ─ on the right. You can do it on the right along the intercostal interval, ─ explained Alexander Bogachev-Prokofiev, director of the Institute of Circulatory Pathology of the National Medical Research Center named after Meshalkina. | |
According to him, the anatomical feature provided an opportunity to avoid partial sternotomy (sternal dissection), preserving its integrity, and perform the entire volume of intervention through access in the second intercostal space along the front surface of the chest. A technically complex intervention through a small 6.5 cm access was allowed by the accumulated experience in the field of mini-invasive technologies and aortic surgery, he said.
According to the doctors of the clinic, the advantage of this technology is the complete preservation of the bone structures of the sternum. This reduces the risk of infectious complications after surgery. They also note that after the operation there is rapid rehabilitation.
During the operation, surgeons eliminated the sagging of both valve valves - they collected their free edges with several sutures and narrowed the diameter of the fibrous ring to normal values. Also, doctors replaced the dilated part of the aorta with a vascular prosthesis with the preservation of the patient's aortic valve.[5]
WhiteSwell Announcement - Catheter System for Acute Heart Failure
At the end of January 2021, the Irish company WhiteSwell introduced a catheter system for the treatment of acute decompensated heart failure (SLDS). The latest technology consists of a paddle pump catheter, which is designed to stimulate lymphatic drainage, which reduces swelling without the use of diuretics. Read more here.
2020
Moray Clipper TEER robotic catheter for heart disease announced
At the end of October 2020, it became known that the California company Moray Medical developed robotic catheter for the treatment of heart disease, and also introduced a number of technologies to facilitate the work of a cardiac surgeon, including - AR programs and a digital three-dimensional interface. More. here
Surgeons in the Moscow region performed a unique operation to remove a tumor on the open heart
In July 2020, it became known about a unique operation in the Moscow region to remove a tumor on the open heart. Doctors of the Moscow Regional Research Clinical Institute named after Vladimirsky (MONICA) rescued a resident of Zhukovsky near Moscow.
A tomographic study revealed in a 56-year-old resident of the city of Zhukovsky near Moscow a tumor-like formation of the right lung measuring more than 6 centimeters. It turned out that her disease had been secretive for a long time and manifested itself only in the summer of this year in the form of a severe cough. According to the results of fluorography, the patient was diagnosed with medial pneumonia.
After the consultation of MONICA doctors, it was decided to urgently perform video thoracoscopic surgery, since a massive malignant tumor affected most of the right lung, actively sprouted into the mediastinum and pericardium. That is, she affected the activities of the heart and threatened the patient's life. Since the tumor passed through all the layers of the anterior wall of the right atrium, surgeons had to do jewelry work on the open heart and without the use of an artificial circulation machine, otherwise the progressive decay of the tumor could lead to fatal bleeding.
An economical thoracotomy was performed, most of the anterior wall of the right atrium was resected, and the entire right lung with all mediastinal lymph nodes was removed. The operation, which was carried out by the head of the thoracic department of MONICA, Professor Alexander Allakhverdyan, lasted just over three hours, and the blood loss was less than 300 milliliters. Immediately after the operation, the patient was transferred to independent breathing with a complete restoration of consciousness, and a day later she could independently move around the department.[6]
2019
Open Chest Dummy
The video below shows an open chest dummy.
Heart connected to a heart lung machine
This is what organs look like before transplantation (2019).
In the video below, the heart is preparing for a transplant.
See also
Notes
- ↑ Military cardiac surgeons of the Russian Federation transplanted the artificial left ventricle of the heart for the first time
- ↑ Variant of the "Turkish saber" syndrome: the rarest congenital heart defect was corrected by surgeons of the Meshalkin Center
- ↑ "Will be able to live an ordinary life": in Samara, doctors for the first time in Russia installed a heart valve from donor tissues for the child
- ↑ Duke health performs world’s first partial heart transplant
- ↑ The Meshalkin Center performed a 36-year-old patient who is unique in world surgical practice
- ↑ MONICA'S doctors performed unique surgery to remove open heart tumour
| The site content is translated by machine translation software powered by PROMT. The machine-translated articles are not always perfect and may contain errors in vocabulary, syntax or grammar. Read original article If you find inaccuracies or errors in the results of machine translation, please write to editor@tadviser.ru. We will make every effort to correct them as soon as possible. |